New Vaccines Against Otitis Media: Projected Benefits and Cost-effectiveness
- 1 June 2009
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 123 (6) , 1452-1463
Abstract
OBJECTIVE. New vaccines that offer protection against otitis media caused by nontypeable Haemophilus influenzae and by Moraxella catarrhalis are under development. However, the potential health benefits and economic effects of such candidate vaccines have not been systematically assessed.Keywords
This publication has 41 references indexed in Scilit:
- Trends in Otitis Media Treatment Failure and RelapsePediatrics, 2008
- Emergence of a Multiresistant Serotype 19A Pneumococcal Strain Not Included in the 7-Valent Conjugate Vaccine as an Otopathogen in ChildrenJAMA, 2007
- Cost Effectiveness of Pertussis Vaccination in AdultsAmerican Journal of Preventive Medicine, 2007
- Brief review of the clinical effectiveness of PREVENAR® against otitis mediaVaccine, 2007
- Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United StatesPediatrics, 2007
- Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of ChildrenEmerging Infectious Diseases, 2006
- Pertussis in Adolescents and Adults: Should We Vaccinate?Pediatrics, 2005
- Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis MediaNew England Journal of Medicine, 2001
- Efficacy of myringotomy with and without tympanostomy tubes for chronic otitis media with effusionThe Pediatric Infectious Disease Journal, 1992
- The impact of otitis mediaThe Pediatric Infectious Disease Journal, 1989